Macula Society Research Grant

The purpose of the MSRG program is to provide funding for clinically relevant research into macular or retinal vascular diseases. Pilot projects with the potential to obtain additional external funding and projects coordinating the efforts of the general membership are preferred. Projects that already receive or are expected to receive $50,000 or more from other sources are not eligible for the Macula Society Research Grant Program. Members who received a research grant in the past three years are not eligible.

Program Description (PDF)

2017-2018 Research Grant Application

The due date for applications will be December 1, 2017 at 5 PM EST.

Macula Society Members Eligible: please log in here to access application forms

Research Grant Overview 

  1. We have $30,000 per year available to support research endeavors of the members of the Society. Recognizing the increasing costs of conducting research and in an attempt to stimulate more interest in generating more applications while respecting the wishes of the Retina Research Foundation, it was agreed that we would fund one project each year for a higher amount rather than giving two grants at a lower amount. The ranking and funding of a proposal will be determined by the Research Committee depending on several criteria based upon (i) the project design (ii) the project feasibility (iii) the project significance. The ranking will then be presented to the Executive Committee and final funding approval determined. 
  1. The due date for applications will be December 1, 2017 at 5 PM EST on the Macula Society web site. These should be submitted on line to allow easy transmittal to the various research committee members. The Macula Society Office will then disseminate the received applications to Committee members who will evaluate and rank them and make recommendations to the Chair for funding. These summaries will then be returned both to the Chair and Society secretary who will tally these numerical scores from which the final recommendations will be made. The funds will be released and the winner will be announced at the time of the 2018 Annual Meeting. 
  1. No member of the Executive Committee or Research Committee may apply for this award during their time of service. 
  1. Due to monetary restrictions, past Retina Research Foundation Award recipients are ineligible for this award. Click here for past recipients of a Retina Research Foundation grant who are ineligible to apply for the MSRG, or you may review the list on the Research Foundation site, http://retinaresearchfnd.org/research-programs/awardhistory/ 

 Funding Guidelines: 

  1. The proposed research must have the potential of increasing the understanding of macular or retinal diseases. Grant proposals facilitating collaboration among the Macula Society members to study a particular disease are encouraged as well. Research receiving partial funding from sources additional to this MSRG award is also eligible, as the Macula Society believes that their support may encourage others to fund research. 
  1. Funds are to be applied to equipment, supplies, and non-physician salary support. 
  1. Research must conform to accepted standards of conduct (e.g., ARVO Guidelines for Use of Animals in Research), and is to receive institutional approval by the appropriate review committees (e.g., Animal Care Committee, Human Research Review Committee, etc.). 
  1. The duration of the research project must not exceed 18 months. Research monies not disbursed during this time will be returned to the Macula Society. 
  1. The firm deadline for receipt of an application is listed above. All applications must be submitted online through the Macula Society web site, www.maculasociety.org. 
  1. Members of the Grant Application Review Committee consist of the Macula Society Research and Education Committee, who, as members, are ineligible for consideration of these awards. Members of the Executive Committee are also ineligible for consideration. 
  1. Award recipients must acknowledge the support of the Macula Society Research Award Grant Program on all papers, presentations, and abstracts regarding the supported research. 
  1. Each recipient must present their research project to the Macula Society within two years of receiving an award. The presentation will be given in a specially designated section of the Annual Meeting of the Macula Society. 
  1. An audit of funds may be requested by the Macula Society at the completion of the project. 

The 2017-2018 Research Grant application is available after logging into the Macula Society web site and clicking on "2017-2018 Research Grant Program Application" from your personal profile. 

              Research Grant Recipients

              2017

              M.E. Hartnett
              Novel Gene Therapy to Regulate Pathologic Neovascularization in AMD

              2016

              Christine A. Curcio, PhD
              Visualizing organelles in human retinal pigment epithelium by 3-dimensional electron microscopy

              2015

              Robyn Heather Guymer, MD
              The role of reduced phagocytosis in the pathogenesis of AMD

              2013

              Demetrios Vavvas, MD
              Role of RIP3 Kinase in Inflammation and Photoreceptor Cell Loss

              2012

              Kang Zhang, M.D.
              Using AMD Patient iPSCs for RPE Differentiation and Disease Modeling

               

              Amani Fawzi, M.D.
              Platform for long-term Delivery of Anti-Angiogenic Peptides for Intravitreal Treatment of Neovascular Eye Disease

               

              Milam A. Brantley, Jr., M.D., PhD.
              Small molecule-mediated differential expression of HTRA1 and ARMS2 to elucidate gene function in AMD

              2011

              Stephen Tsang, MD, PhD
              Genetic and Environmental Factors in AMD

              Click here for a link to the report on youtube.

              tsang

               

              Stephen Jae Kim, MD
              Safety, Pharmacokinetics, and Efficacy of Celecoxib and Valdecoxib after Intraocular Administration for Macular Edema

              kim

              2010

              J. William Harbour, MD
              Development of a blood test to diagnose uveal melanoma

              harbour

              2009

              Rajendra S. Apte, MD
              Wnt Signaling in Choroidal Neovascularization

              Apte

               

              Lloyd P. Aiello, MD
              Treatment with Oral Rosiglitazone to Prevent the Progression of Diabetic Retinopathy in eyes at high risk of developing proliferative disease

              AIELLO

              2007

              Paul Sternberg, MD
              Plasma proinflammatory biomarkers in patients with age-related macular degeneration

              sternberg

               

              Jose Pulido, MD
              Activation State fo Immune Cells in the Human Choriod

              PULIDOJOSE
              Member Login

              Officers

              President
              James C. Folk, MD

              President-Elect
              H. Richard McDonald, MD

              Secretary
              Joan W. Miller, MD

              Treasurer
              Carol L. Shields, MD

              Executive Secretary
              Lawrence J.  Singerman, MD

              Established 1977
              Lawrence Singerman - Founder

              Committee Chairs

              Awards
              M. Gilbert Grand, MD

              By-Laws Chair
              Ivana Kim, MD

              Credentials
              Glenn J. Jaffe, MD

              Meeting Planning
              Peter K. Kaiser, MD

              Nominating
              Jennifer I. Lim, MD

              Program
              Srini Vas Sadda, MD

              Research & Education
              Richard F. Spaide, MD

              Website
              Cynthia Toth, MD

              AAO Representative
              Michael J. Elman, MD

              International Representative
              Gabriel J. Coscas, MD

              Young Member
              R.V. Paul Chan, MD

              Past Presidents

              Arnall Patz, MD
              J. Donald M. Gass, MD
              Morton F. Goldberg, MD
              Robert C. Watzke, MD
              Stephen J. Ryan, MD
              John G. Clarkson, MD
              David H. Orth, MD
              Alexander J. Brucker, MD
              Lee M. Jampol, MD
              Thomas M. Aaberg, MD
              Travis A. Meredith, MD
              Kurt A. Gitter, MD
              William F. Mieler, MD
              Daniel Finkelstein, MD
              Lawrence A. Yannuzzi, MD
              Evangelos S. Gragoudas, MD
              Jerry A. Shields, MD
              Michael L. Klein, MD
              Emily Y. Chew, MD
              Mark S. Blumenkranz, MD
              Neil M. Bressler, MD
              Paul Sternberg, Jr., MD
              Gil Grand, MD

              Andrew P. Schachat, MD

              Conference Management Software by X-CD Technologies Inc.